These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 11938357)
1. Recombinant tissue plasminogen activator for acute ischemic stroke. Al-Buhairi AR; Jan MM Saudi Med J; 2002 Jan; 23(1):13-9. PubMed ID: 11938357 [TBL] [Abstract][Full Text] [Related]
2. Recombinant tissue plasminogen activator for acute ischemic stroke. Al-Buhairi AR; Jan MM Neurosciences (Riyadh); 2002 Jan; 7(1):7-13. PubMed ID: 23978882 [TBL] [Abstract][Full Text] [Related]
3. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152 [TBL] [Abstract][Full Text] [Related]
4. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan. Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704 [TBL] [Abstract][Full Text] [Related]
5. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital]. Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212 [TBL] [Abstract][Full Text] [Related]
6. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature. Cremer S; Berliner Y; Warren D; Jones AE CJEM; 2008 Nov; 10(6):575-8. PubMed ID: 19000355 [TBL] [Abstract][Full Text] [Related]
8. Treatment of acute ischemic stroke: intravenous and endovascular therapies. Jahan R; Vinuela F Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062 [TBL] [Abstract][Full Text] [Related]
9. [Prospects of thrombolytic therapy for acute ischemic stroke]. Nakashima T; Minematsu K Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399 [TBL] [Abstract][Full Text] [Related]
12. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience. National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134 [TBL] [Abstract][Full Text] [Related]
13. Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke. Hafeez F; Razzaq MA; Levine RL; Ramirez MA J Stroke Cerebrovasc Dis; 2007; 16(6):273-7. PubMed ID: 18035246 [TBL] [Abstract][Full Text] [Related]
14. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit. Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188 [TBL] [Abstract][Full Text] [Related]
15. Trombolysis in acute stroke. Schwammenthal Y; Tsabari R; Bakon M; Orion D; Merzeliak O; Tanne D Isr Med Assoc J; 2006 Nov; 8(11):784-7. PubMed ID: 17180831 [TBL] [Abstract][Full Text] [Related]
16. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital. Hsu YC; Sung SF; Ong CT; Wu CS; Su YH Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569 [TBL] [Abstract][Full Text] [Related]
17. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Allen NB; Myers D; Watanabe E; Dostal J; Sama D; Goldstein LB; Lichtman JH Cerebrovasc Dis; 2009; 27(3):254-8. PubMed ID: 19176959 [TBL] [Abstract][Full Text] [Related]
18. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis. Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237 [TBL] [Abstract][Full Text] [Related]
19. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience. Simon JE; Sandler DL; Pexman JH; Hill MD; Buchan AM; Age Ageing; 2004 Mar; 33(2):143-9. PubMed ID: 14960429 [TBL] [Abstract][Full Text] [Related]
20. Treatment of acute ischemic stroke. Lewandowski C; Barsan W Ann Emerg Med; 2001 Feb; 37(2):202-16. PubMed ID: 11174240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]